<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>28038924</identifier>
<setSpec>1989-7286</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Pardo Saiz, A O</dc:author>
<dc:author>Guixeres Esteve, M C</dc:author>
<dc:description xml:lang="en">CLINICAL CASE A 14 year-old boy with Coats' disease in his right eye, presented with a visual acuity (VA) of 0.1, micro-aneurysms, exudates, a macular oedema of 959 microns, and peripheral telangiectasias. After 12 months follow-up with 6 ranibizumab injections and 3 sessions of argon laser photocoagulation, the macular oedema remained and VA was 0.2. Following 4 aflibercept injections and another 2 laser sessions, he had a good foveal slope and a VA of 0.5, with no recurrences in the last 12 months. DISCUSSION Treatment with aflibercept and argon laser was effective in our patient with stage 2B Coats' disease and macular oedema unresponsive to ranibizumab.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Enfermedad de Coats</dc:subject>
<dc:subject>Ranibizumab</dc:subject>
<dc:subject>Argon laser</dc:subject>
<dc:subject>Aflibercept</dc:subject>
<dc:subject>Coats’ disease</dc:subject>
<dc:subject>Láser argón</dc:subject>
<dc:date>2017 Jul </dc:date>
<dc:title xml:lang="es">Enfermedad de Coats con edema macular sensible al aflibercept y láser argón.</dc:title>
<dc:title xml:lang="en">Coats' disease with macular oedema responsive to aflibercept and argon laser.</dc:title>
<dc:publisher>Archivos de la Sociedad Espanola de Oftalmologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
